{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:01:50Z","timestamp":1793419310567,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Succinate is produced by both host and microbiota, with a key role in the interplay of immunity and metabolism and an emerging role as a biomarker for inflammatory and metabolic disorders in middle-aged adults. The relationship between plasma succinate levels and cardiovascular disease (CVD) risk in young adults is unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Cross-sectional study in 100 (65% women) individuals aged 18\u201325\u00a0years from the ACTIvating Brown Adipose Tissue through Exercise (ACTIBATE) study cohort. CVD risk factors, body composition, dietary intake, basal metabolic rate, and cardiorespiratory fitness were assessed by routine methods. Plasma succinate was measured with an enzyme-based assay. Brown adipose tissue (BAT) was evaluated by positron emission tomography, and circulating oxylipins were assessed by targeted metabolomics. Fecal microbiota composition was analyzed in a sub-sample.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Individuals with higher succinate levels had higher levels of visceral adipose tissue (VAT) mass (+\u200942.5%), triglycerides (+\u200963.9%), C-reactive protein (+\u2009124.2%), diastolic blood pressure (+\u20095.5%), and pro-inflammatory omega-6 oxylipins than individuals with lower succinate levels. Succinate levels were also higher in metabolically unhealthy individuals than in healthy overweight\/obese peers. Succinate levels were not associated with BAT volume or activity or with fecal microbiota composition and diversity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Plasma succinate levels are linked to a specific pro-inflammatory omega-6 signature pattern and higher VAT levels, and seem to reflect the cardiovascular status of young adults.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-021-01333-3","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T09:03:00Z","timestamp":1627376580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Elevated plasma succinate levels are linked to higher cardiovascular disease risk factors in young adults"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6546-9534","authenticated-orcid":false,"given":"Francisco J.","family":"Osuna-Prieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-1859","authenticated-orcid":false,"given":"Borja","family":"Martinez-Tellez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6827-2358","authenticated-orcid":false,"given":"Lourdes","family":"Ortiz-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2785-9320","authenticated-orcid":false,"given":"Xinyu","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5254-1816","authenticated-orcid":false,"given":"Lucas","family":"Jurado-Fasoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2308-7140","authenticated-orcid":false,"given":"Huiwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4460-9761","authenticated-orcid":false,"given":"Victoria","family":"Ceperuelo-Mallafr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2764-5610","authenticated-orcid":false,"given":"Catalina","family":"N\u00fa\u00f1ez-Roa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3629-1597","authenticated-orcid":false,"given":"Isabelle","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5564-5338","authenticated-orcid":false,"given":"Antonio","family":"Segura-Carretero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 V.","family":"Garc\u00eda-Lario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7663-0939","authenticated-orcid":false,"given":"Angel","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1451-4788","authenticated-orcid":false,"given":"Concepci\u00f3n M.","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4661-5030","authenticated-orcid":false,"given":"Jose M.","family":"Llamas-Elvira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-4988","authenticated-orcid":false,"given":"Patrick C. N.","family":"Rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6994-6115","authenticated-orcid":false,"given":"Joan","family":"Vendrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7548-7138","authenticated-orcid":false,"given":"Jonatan R.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2906-3788","authenticated-orcid":false,"given":"Sonia","family":"Fern\u00e1ndez-Veledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,27]]},"reference":[{"key":"1333_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrcardio.2010.178","volume":"8","author":"R Vedanthan","year":"2011","unstructured":"Vedanthan R, Fuster V. Urgent need for human resources to promote global cardiovascular health. Nat Rev Cardiol. 2011;8:114\u20137.","journal-title":"Nat Rev Cardiol"},{"key":"1333_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nrcardio.2017.154","volume":"15","author":"C Andersson","year":"2018","unstructured":"Andersson C, Vasan RS. Epidemiology of cardiovascular disease in young individuals. Nat Rev Cardiol. 2018;15:230\u201340.","journal-title":"Nat Rev Cardiol"},{"key":"1333_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/CIRCRESAHA.116.309955","volume":"120","author":"MR Thomas","year":"2017","unstructured":"Thomas MR, Lip GYH. Novel risk markers and risk assessments for cardiovascular disease. Circ Res. 2017;120:133\u201349.","journal-title":"Circ Res"},{"key":"1333_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-019-0813-5","volume":"18","author":"K Oluwagbemigun","year":"2019","unstructured":"Oluwagbemigun K, Buyken AE, Alexy U, Schmid M, Herder C, N\u00f6thlings U. Developmental trajectories of body mass index from childhood into late adolescence and subsequent late adolescence-young adulthood cardiometabolic risk markers. Cardiovasc Diabetol. 2019;18:1\u201314.","journal-title":"Cardiovasc Diabetol"},{"key":"1333_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-019-0846-9","volume":"18","author":"E Gourgari","year":"2019","unstructured":"Gourgari E, Ma J, Playford MP, Mehta NN, Goldman R, Remaley AT, et al. Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study. Cardiovasc Diabetol. 2019;18:1\u201311.","journal-title":"Cardiovasc Diabetol"},{"key":"1333_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/met.2019.0073","volume":"18","author":"R Parsanathan","year":"2020","unstructured":"Parsanathan R, Jain SK. Novel invasive and noninvasive cardiac-specific biomarkers in obesity and cardiovascular diseases. Metab Syndr Relat Disord. 2020;18:10\u201330.","journal-title":"Metab Syndr Relat Disord"},{"key":"1333_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pcad.2012.06.004","volume":"55","author":"T Senn","year":"2012","unstructured":"Senn T, Hazen SL, Tang WHW. Translating metabolomics to cardiovascular biomarkers. Prog Cardiovasc Dis. 2012;55:70\u20136.","journal-title":"Prog Cardiovasc Dis"},{"key":"1333_CR8","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1098\/rsfs.2016.0100","volume":"7","author":"C Frezza","year":"2017","unstructured":"Frezza C. Mitochondrial metabolites: undercover signalling molecules. Interface Focus. 2017;7:0\u20135.","journal-title":"Interface Focus"},{"key":"1333_CR9","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3324\/haematol.2018.196097","volume":"103","author":"F Grimolizzi","year":"2018","unstructured":"Grimolizzi F, Arranz L. Multiple faces of succinate beyond metabolism in blood. Haematologica. 2018;103:1586\u201392.","journal-title":"Haematologica"},{"key":"1333_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani ET, Pell VR, Gaude E, Aksentijevi\u0107 D, Sundier SY, Robb EL, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515:431\u20135.","journal-title":"Nature"},{"key":"1333_CR11","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1084\/jem.20160061","volume":"213","author":"A Littlewood-Evans","year":"2016","unstructured":"Littlewood-Evans A, Sarret S, Apfel V, Loesle P, Dawson J, Zhang J, et al. GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. J Exp Med. 2016;213:1655\u201362.","journal-title":"J Exp Med"},{"key":"1333_CR12","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/ni.1657","volume":"9","author":"T Rubic","year":"2008","unstructured":"Rubic T, Lametschwandtner G, Jost S, Hinteregger S, Kund J, Carballido-Perrig N, et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol. 2008;9:1261\u20139.","journal-title":"Nat Immunol"},{"key":"1333_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, et al. Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature. 2013;496:238\u201342.","journal-title":"Nature"},{"key":"1333_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41590-019-0372-7","volume":"20","author":"N Keiran","year":"2019","unstructured":"Keiran N, Ceperuelo-Mallafr\u00e9 V, Calvo E, Hern\u00e1ndez-Alvarez MI, Ejarque M, N\u00fa\u00f1ez-Roa C, et al. SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity. Nat Immunol. 2019;20:581\u201392.","journal-title":"Nat Immunol"},{"key":"1333_CR15","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.1073\/pnas.1720758115","volume":"115","author":"W Lei","year":"2018","unstructured":"Lei W, Ren W, Ohmoto M, Urban JF, Matsumoto I, Margolskee RF, et al. Activation of intestinal tuft cell-expressed sucnr1 triggers type 2 immunity in the mouse small intestine. Proc Natl Acad Sci USA. 2018;115:5552\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1333_CR16","doi-asserted-by":"publisher","first-page":"355.e13","DOI":"10.1016\/j.stem.2018.01.020","volume":"22","author":"L Peruzzotti-Jametti","year":"2018","unstructured":"Peruzzotti-Jametti L, Bernstock JD, Vicario N, Costa ASH, Kwok CK, Leonardi T, et al. Macrophage-derived extracellular succinate licenses neural stem cells to suppress chronic neuroinflammation. Cell Stem Cell. 2018;22:355.e13-368.e13.","journal-title":"Cell Stem Cell"},{"key":"1333_CR17","doi-asserted-by":"publisher","first-page":"33.e7","DOI":"10.1016\/j.immuni.2018.06.016","volume":"49","author":"MS Nadjsombati","year":"2018","unstructured":"Nadjsombati MS, McGinty JW, Lyons-Cohen MR, Jaffe JB, DiPeso L, Schneider C, et al. Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit. Immunity. 2018;49:33.e7-41.e7. https:\/\/doi.org\/10.1016\/j.immuni.2018.06.016.","journal-title":"Immunity"},{"key":"1333_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cmet.2016.06.013","volume":"24","author":"F De Vadder","year":"2016","unstructured":"De Vadder F, Kovatcheva-Datchary P, Zitoun C, Duchampt A, B\u00e4ckhed F, Mithieux G. Microbiota-produced succinate improves glucose homeostasis via intestinal gluconeogenesis. Cell Metab. 2016;24:151\u20137.","journal-title":"Cell Metab"},{"key":"1333_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-018-0353-2","volume":"560","author":"EL Mills","year":"2018","unstructured":"Mills EL, Pierce KA, Jedrychowski MP, Garrity R, Winther S, Vidoni S, et al. Accumulation of succinate controls activation of adipose tissue thermogenesis. Nature. 2018;560:102\u20136.","journal-title":"Nature"},{"key":"1333_CR20","doi-asserted-by":"publisher","first-page":"62.e17","DOI":"10.1016\/j.cell.2020.08.039","volume":"183","author":"A Reddy","year":"2020","unstructured":"Reddy A, Bozi LHM, Yaghi OK, Mills EL, Xiao H, Nicholson HE, et al. pH-gated succinate secretion regulates muscle remodeling in response to exercise. Cell. 2020;183:62.e17-75.e17.","journal-title":"Cell"},{"key":"1333_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embr.201947892","volume":"20","author":"T Wang","year":"2019","unstructured":"Wang T, Xu Y, Yuan Y, Xu P, Zhang C, Li F, et al. Succinate induces skeletal muscle fiber remodeling via SUCNR1 signaling. EMBO Rep. 2019;20:1\u201316.","journal-title":"EMBO Rep"},{"key":"1333_CR22","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.2337\/dc20-0460","volume":"43","author":"B Astiarraga","year":"2020","unstructured":"Astiarraga B, Mart\u00ednez L, Ceperuelo-Mallafr\u00e9 V, Llaurad\u00f3 G, Terr\u00f3n-Puig M, Rodr\u00edguez MM, et al. Impaired succinate response to a mixed meal in obesity and type 2 diabetes is normalized after metabolic surgery. Diabetes Care. 2020;43:2581\u20137.","journal-title":"Diabetes Care"},{"key":"1333_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11154-019-09513-z","volume":"20","author":"S Fern\u00e1ndez-Veledo","year":"2019","unstructured":"Fern\u00e1ndez-Veledo S, Vendrell J. Gut microbiota-derived succinate: friend or foe in human metabolic diseases? Rev Endocr Metab Disord. 2019;20:439\u201347.","journal-title":"Rev Endocr Metab Disord"},{"key":"1333_CR24","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.2337\/dc19-0114","volume":"42","author":"V Ceperuelo-Mallafr\u00e9","year":"2019","unstructured":"Ceperuelo-Mallafr\u00e9 V, Llaurad\u00f3 G, Keiran N, Benaiges E, Astiarraga B, Mart\u00ednez L, et al. Preoperative circulating succinate levels as a biomarker for diabetes remission after bariatric surgery. Diabetes Care. 2019;42:1956\u201365.","journal-title":"Diabetes Care"},{"key":"1333_CR25","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1007\/s00125-017-4261-z","volume":"60","author":"JA van Diepen","year":"2017","unstructured":"van Diepen JA, Robben JH, Hooiveld GJ, Carmone C, Alsady M, Boutens L, et al. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes. Diabetologia. 2017;60:1304\u201313.","journal-title":"Diabetologia"},{"key":"1333_CR26","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1038\/s41396-018-0068-2","volume":"12","author":"C Serena","year":"2018","unstructured":"Serena C, Ceperuelo-Mallafr\u00e9 V, Keiran N, Queipo-Ortu\u00f1o MI, Bernal R, Gomez-Huelgas R, et al. Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota. ISME J. 2018;12:1642\u201357.","journal-title":"ISME J"},{"key":"1333_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.plefa.2018.06.005","volume":"137","author":"GC Shearer","year":"2018","unstructured":"Shearer GC, Walker RE. An overview of the biologic effects of omega-6 oxylipins in humans. Prostaglandins Leukot Essent Fat Acids. 2018;137:26\u201338.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"1333_CR28","doi-asserted-by":"publisher","first-page":"102157","DOI":"10.1016\/j.plefa.2020.102157","volume":"160","author":"R Tans","year":"2020","unstructured":"Tans R, Bande R, van Rooij A, Molloy BJ, Stienstra R, Tack CJ, et al. Evaluation of cyclooxygenase oxylipins as potential biomarker for obesity-associated adipose tissue inflammation and type 2 diabetes using targeted multiple reaction monitoring mass spectrometry. Prostaglandins Leukot Essent Fat Acids. 2020;160:102157. https:\/\/doi.org\/10.1016\/j.plefa.2020.102157.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"1333_CR29","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1194\/jlr.R900004-JLR200","volume":"50","author":"MW Buczynski","year":"2009","unstructured":"Buczynski MW, Dumlao DS, Dennis EA. An integrated omics analysis of eicosanoid biology. J Lipid Res. 2009;50:1015\u201338.","journal-title":"J Lipid Res"},{"key":"1333_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/18715303113139990041","volume":"7","author":"CMO Volpe","year":"2013","unstructured":"Volpe CMO, Nogueira-Machado JA. The dual role of free fatty acid signaling in inflammation and therapeutics. Recent Pat Endocr Metab Immune Drug Discov. 2013;7:189\u201397.","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"1333_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3945\/an.114.007732","volume":"6","author":"M Gabbs","year":"2015","unstructured":"Gabbs M, Leng S, Devassy JG, Aukema HM. Advances in our understanding of oxylipins derived from dietary PUFAs. Adv Nutr. 2015;6:513\u201340.","journal-title":"Adv Nutr"},{"key":"1333_CR32","doi-asserted-by":"publisher","first-page":"H903","DOI":"10.1152\/ajpheart.00201.2017","volume":"313","author":"SPB Caligiuri","year":"2017","unstructured":"Caligiuri SPB, Parikh M, Stamenkovic A, Pierce GN, Aukema HM. Dietary modulation of oxylipins in cardiovascular disease and aging. Am J Physiol Heart Circ Physiol. 2017;313:H903\u201318.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1333_CR33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cct.2015.11.004","volume":"45","author":"G Sanchez-delgado","year":"2015","unstructured":"Sanchez-delgado G, Martinez-tellez B, Olza J, Aguilera CM, Labayen I, Ortega FB, et al. Activating brown adipose tissue through exercise (ACTIBATE) in young adults: rationale, design and methodology. Contemp Clin Trials. 2015;45:416\u201325.","journal-title":"Contemp Clin Trials"},{"key":"1333_CR34","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1161\/CIRCRESAHA.115.306883","volume":"118","author":"FB Ortega","year":"2016","unstructured":"Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. 2016;118:1752\u201370.","journal-title":"Circ Res"},{"key":"1333_CR35","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"1333_CR36","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.2337\/dc19-0114","volume":"42","author":"V Ceperuelo-Mallafre","year":"2019","unstructured":"Ceperuelo-Mallafre V, Llaurado G, Keiran N, Benaiges E, Astiarraga B, Martinez L, et al. Preoperative circulating succinate levels as a biomarker for diabetes remission after bariatric surgery. Diabetes Care. 2019;42:1956\u201365.","journal-title":"Diabetes Care"},{"key":"1333_CR37","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ, Ross R, Despr\u00e9s JP, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7:715\u201325.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1333_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"M Ruiz-Castell","year":"2021","unstructured":"Ruiz-Castell M, Samouda H, Bocquet V, Fagherazzi G, Stranges S, Huiart L. Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study. Sci Rep. 2021;11:1\u20139.","journal-title":"Sci Rep"},{"key":"1333_CR39","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/eurheartj\/ehaa823","volume":"42","author":"H Sorimachi","year":"2021","unstructured":"Sorimachi H, Obokata M, Takahashi N, Reddy YNV, Jain CC, Verbrugge FH, et al. Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction. Eur Heart J. 2021;42:1595\u2013605.","journal-title":"Eur Heart J"},{"key":"1333_CR40","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.2337\/dc09-0259","volume":"32","author":"K Park","year":"2009","unstructured":"Park K, Gross M, Lee DH, Holvoet P, Himes JH, Shikany JM, et al. Oxidative stress and insulin resistance: the coronary artery risk development in young adults study. Diabetes Care. 2009;32:1302\u20137.","journal-title":"Diabetes Care"},{"key":"1333_CR41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/CIRCRESAHA.114.300559","volume":"114","author":"YR Chen","year":"2014","unstructured":"Chen YR, Zweier JL. Cardiac mitochondria and reactive oxygen species generation. Circ Res. 2014;114:524\u201337.","journal-title":"Circ Res"},{"key":"1333_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.115.002555","volume":"5","author":"AL Sverdlov","year":"2016","unstructured":"Sverdlov AL, Elezaby A, Qin F, Behring JB, Luptak I, Calamaras TD, et al. Mitochondrial reactive oxygen species mediate cardiac structural, functional, and mitochondrial consequences of diet-induced metabolic heart disease. J Am Heart Assoc. 2016;5:1\u201313.","journal-title":"J Am Heart Assoc"},{"key":"1333_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.yjmcc.2014.07.018","volume":"78","author":"AL Sverdlov","year":"2015","unstructured":"Sverdlov AL, Elezaby A, Behring JB, Bachschmid MM, Luptak I, Tu VH, et al. High fat, high sucrose diet causes cardiac mitochondrial dysfunction due in part to oxidative post-translational modification of mitochondrial complex II. J Mol Cell Cardiol. 2015;78:165\u201373.","journal-title":"J Mol Cell Cardiol"},{"key":"1333_CR44","doi-asserted-by":"publisher","first-page":"E168","DOI":"10.1152\/ajpendo.00227.2018","volume":"316","author":"DTM Ngo","year":"2019","unstructured":"Ngo DTM, Sverdlov AL, Karki S, Macartney-Coxson D, Stubbs RS, Farb MG, et al. Oxidative modifications of mitochondrial complex ii are associated with insulin resistance of visceral fat in obesity. Am J Physiol Endocrinol Metab. 2019;316:E168\u201377.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1333_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","volume":"15","author":"EE Canfora","year":"2019","unstructured":"Canfora EE, Meex RCR, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 2019;15:261\u201373.","journal-title":"Nat Rev Endocrinol"},{"key":"1333_CR46","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.2337\/db14-0346","volume":"64","author":"KJ McCreath","year":"2015","unstructured":"McCreath KJ, Espada S, G\u00e1lvez BG, Benito M, De Molina A, Sep\u00falveda P, et al. Targeted disruption of the SUCNR1 metabolic receptor leads to dichotomous effects on obesity. Diabetes. 2015;64:1154\u201367.","journal-title":"Diabetes"},{"key":"1333_CR47","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2008.08.040","volume":"135","author":"JB Regard","year":"2008","unstructured":"Regard JB, Sato IT, Coughlin SR. Anatomical profiling of G protein-coupled receptor expression. Cell. 2008;135:561\u201371.","journal-title":"Cell"},{"key":"1333_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF00423282","volume":"35","author":"PW Hochachka","year":"1976","unstructured":"Hochachka PW, Dressendorfer RH. Succinate accumulation in man during exercise. Eur J Appl Physiol Occup Physiol. 1976;35:235\u201342.","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"1333_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40798-018-0138-z","volume":"4","author":"S Nichols","year":"2018","unstructured":"Nichols S, Taylor C, Page R, Kallvikbacka-Bennett A, Nation F, Goodman T, et al. Is cardiorespiratory fitness related to cardiometabolic health and all-cause mortality risk in patients with coronary heart disease? A CARE CR study. Sport Med Open. 2018;4:22.","journal-title":"Sport Med Open"},{"key":"1333_CR50","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.3390\/nu11071652","volume":"11","author":"J Myers","year":"2019","unstructured":"Myers J, Kokkinos P, Nyelin E. Physical activity, cardiorespiratory fitness, and the metabolic syndrome. Nutrients. 2019;11:1652.","journal-title":"Nutrients"},{"key":"1333_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jare.2018.03.005","volume":"11","author":"VS Hanna","year":"2018","unstructured":"Hanna VS, Hafez EAA. Synopsis of arachidonic acid metabolism: a review. J Adv Res. 2018;11:23\u201332.","journal-title":"J Adv Res"},{"key":"1333_CR52","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.biocel.2009.12.013","volume":"42","author":"DW Gilroy","year":"2010","unstructured":"Gilroy DW. Eicosanoids and the endogenous control of acute inflammatory resolution. Int J Biochem Cell Biol. 2010;42:524\u20138.","journal-title":"Int J Biochem Cell Biol"},{"key":"1333_CR53","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nri3859","volume":"15","author":"EA Dennis","year":"2015","unstructured":"Dennis EA, Norris PC. Eicosanoid storm in infection and inflammation. Nat Rev Immunol. 2015;15:511\u201323.","journal-title":"Nat Rev Immunol"},{"key":"1333_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.metabol.2017.01.034","volume":"70","author":"CA Pickens","year":"2017","unstructured":"Pickens CA, Sordillo LM, Zhang C, Fenton JI. Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE). Metabolism. 2017;70:177\u201391.","journal-title":"Metabolism"},{"key":"1333_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.plefa.2014.12.001","volume":"95","author":"CA Pickens","year":"2015","unstructured":"Pickens CA, Sordillo LM, Comstock SS, Harris WS, Hortos K, Kovan B, et al. Plasma phospholipids, non-esterified plasma polyunsaturated fatty acids and oxylipids are associated with BMI. Prostaglandins Leukot Essent Fat Acids. 2015;95:31\u201340.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"1333_CR56","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.freeradbiomed.2008.10.028","volume":"46","author":"IJ Tsai","year":"2009","unstructured":"Tsai IJ, Croft KD, Mori TA, Falck JR, Beilin LJ, Puddey IB, et al. 20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction. Free Radic Biol Med. 2009;46:263\u201370.","journal-title":"Free Radic Biol Med"},{"key":"1333_CR57","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1139\/cjpp-2016-0615","volume":"95","author":"SPB Caligiuri","year":"2017","unstructured":"Caligiuri SPB, Aukema HM, Ravandi A, Lavall\u00e9e R, Guzman R, Pierce GN. Specific plasma oxylipins increase the odds of cardiovascular and cerebrovascular events in patients with peripheral artery disease. Can J Physiol Pharmacol. 2017;95:961\u20138.","journal-title":"Can J Physiol Pharmacol"},{"key":"1333_CR58","first-page":"151","volume":"7","author":"Y Unver","year":"1994","unstructured":"Unver Y, Erden M. Plasma thromboxane B2 and leukotriene B4 levels in patients with coronary atherosclerosis. J Islam Acad Sci. 1994;7:151\u20136.","journal-title":"J Islam Acad Sci"},{"key":"1333_CR59","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.2169\/internalmedicine.0816-18","volume":"57","author":"Y Tsurutani","year":"2018","unstructured":"Tsurutani Y, Inoue K, Sugisawa C, Saito J, Omura M, Nishikawa T. Increased serum dihomo-\u03b3-linolenic acid levels are associated with obesity, body fat accumulation, and insulin resistance in Japanese patients with type 2 diabetes. Intern Med. 2018;57:2929\u201335.","journal-title":"Intern Med"},{"key":"1333_CR60","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jacl.2017.05.003","volume":"11","author":"GE Delgado","year":"2017","unstructured":"Delgado GE, M\u00e4rz W, Lorkowski S, von Schacky C, Kleber ME. Omega-6 fatty acids: opposing associations with risk\u2014the Ludwigshafen risk and cardiovascular health study. J Clin Lipidol. 2017;11:1082-1090.e14.","journal-title":"J Clin Lipidol"},{"key":"1333_CR61","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/nu8030128","volume":"8","author":"AP Simopoulos","year":"2016","unstructured":"Simopoulos AP, Gene O. An increase in the omega-6\/omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8:128.","journal-title":"Nutrients"},{"key":"1333_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2018.00447","volume":"9","author":"AC Carpentier","year":"2018","unstructured":"Carpentier AC, Blondin DP, Virtanen KA, Richard D, Haman F, Turcotte \u00c9E. Brown adipose tissue energy metabolism in humans. Front Endocrinol. 2018;9:1\u201321.","journal-title":"Front Endocrinol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01333-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-021-01333-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01333-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T09:05:39Z","timestamp":1675587939000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-021-01333-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,27]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1333"],"URL":"https:\/\/doi.org\/10.1186\/s12933-021-01333-3","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,27]]},"assertion":[{"value":"21 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants gave their written informed consent. The study protocol and design were approved by the Human Research Ethics Committee of the University of Granada (no. 924) and the Servicio Andaluz de Salud and adhered to the tenets of the Declaration of Helsinki, as revised in 2013.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have on competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}